vidarabine has been researched along with Arthritis, Psoriatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boumpas, DT; Danning, CL; Davis, JC; Fleisher, TA; Illei, GG; Kuroiwa, T; Schlimgen, R; Takada, K; Tassiulas, IO; Yarboro, CH | 1 |
| Nagler, A; Or, R; Slavin, S; Varadi, G | 1 |
1 trial(s) available for vidarabine and Arthritis, Psoriatic
| Article | Year |
|---|---|
Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Psoriatic; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; DNA-Binding Proteins; E-Selectin; Endothelial Cells; Female; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Lymphocyte Depletion; Male; Middle Aged; P-Selectin; Phosphorylation; Prednisone; STAT1 Transcription Factor; Synovial Membrane; Trans-Activators; Vidarabine | 2003 |
1 other study(ies) available for vidarabine and Arthritis, Psoriatic
| Article | Year |
|---|---|
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
Topics: Adult; Antineoplastic Agents; Arthritis, Psoriatic; Autoimmunity; Busulfan; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytes; Male; Psoriasis; Reverse Transcriptase Polymerase Chain Reaction; Vidarabine | 2000 |